Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Dec, 2019 | Pages:
200 | Publisher: The Business Research Company
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Kidney Cancer Drugs Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global kidney cancer drugs market. Reasons to Purchase • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies. • Create regional and country strategies on the basis of local data and analysis. • Identify growth segments for investment. • Outperform competitors using forecast data and the drivers and trends shaping the market. • Understand customers based on the latest market research findings. • Benchmark performance against key competitors. • Utilize the relationships between key data sets for superior strategizing. • Suitable for supporting your internal and external presentations with reliable high quality data and analysis • Report will be updated with the latest data and delivered to you within 3-5 working days of order. Description: Where is the largest and fastest growing market for the kidney cancer drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Kidney Cancer Drugs Market Global Report from The Business Research Company answers all these questions and many more. The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. • The Market Characteristics section of the report defines and explains the market. • The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market. • Market Segmentations break down market into sub markets. • The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing. • Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified. • The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this. Scope Markets Covered: 1) By Type: Renal Cell Carcinoma (RCC), Transitional Cell Carcinoma (TCC) or Urothelial cell carcinoma (UCC) 2) By Product: Nexavar (Sorafenib), Sutent (Sunitinib), Afinitor (Everolimus), Votrient (Pazopanib), Avastin (Bevacizumab), Inlyta (Axitinib),, Torisel (Temsirolimus), Proleukin (Aldesleukin), Others 3) By End Users: Hospitals, Clinics, Research Center, Others Companies Mentioned: Bayer AG, Pfizer Inc, Novartis International AG, Exelixis, Inc, F. Hoffmann-La Roche Ag Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa Time Series: Five years historic and forecast. Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments. Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Table of Contents
1. Executive Summary 2. Kidney Cancer Drugs Market Characteristics 3. Kidney Cancer Drugs Market Size And Growth 3.1. Global Kidney Cancer Drugs Historic Market, 2015 - 2019, $ Billion 3.1.1. Drivers Of The Market 3.1.2. Restraints On The Market 3.2. Global Kidney Cancer Drugs Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion 3.2.1. Drivers Of The Market 3.2.2. Restraints On the Market 4. Kidney Cancer Drugs Market Segmentation 4.1. Global Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Renal Cell Carcinoma (RCC) Transitional Cell Carcinoma (TCC) or Urothelial cell carcinoma (UCC) 4.2. Global Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Nexavar (Sorafenib) Sutent (Sunitinib) Afinitor (Everolimus) Votrient (Pazopanib) Avastin (Bevacizumab) Inlyta (Axitinib), Torisel (Temsirolimus) Proleukin (Aldesleukin) Others 4.3. Global Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Hospitals Clinics Research Center Other 5. Kidney Cancer Drugs Market Regional And Country Analysis 5.1. Global Kidney Cancer Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 5.2. Global Kidney Cancer Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 6. Asia-Pacific Kidney Cancer Drugs Market 6.1. Asia-Pacific Kidney Cancer Drugs Market Overview 6.2. Asia-Pacific Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 6.3. Asia-Pacific Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 6.4. Asia-Pacific Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 7. China Kidney Cancer Drugs Market 7.1. China Kidney Cancer Drugs Market Overview 7.2. China Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion 7.3. China Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion 7.4. China Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion 8. India Kidney Cancer Drugs Market 8.1. India Kidney Cancer Drugs Market Overview 8.2. India Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 8.3. India Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 8.4. India Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 9. Japan Kidney Cancer Drugs Market 9.1. Japan Kidney Cancer Drugs Market Overview 9.2. Japan Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 9.3. Japan Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 9.4. Japan Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 10. Australia Kidney Cancer Drugs Market 10.1. Australia Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 10.2. Australia Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 10.3. Australia Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 11. Indonesia Kidney Cancer Drugs Market 11.1. Indonesia Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 11.2. Indonesia Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 11.3. Indonesia Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 12. South Korea Kidney Cancer Drugs Market 12.1. South Korea Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 12.2. South Korea Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 12.3. South Korea Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 13. Western Europe Kidney Cancer Drugs Market 13.1. Western Europe Kidney Cancer Drugs Market Overview 13.2. Western Europe Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 13.3. Western Europe Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 13.4. Western Europe Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 14. UK Kidney Cancer Drugs Market 14.1. UK Kidney Cancer Drugs Market Overview 14.2. UK Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 14.3. UK Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 14.4. UK Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 15. Germany Kidney Cancer Drugs Market 15.1. Germany Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 15.2. Germany Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 15.3. Germany Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 16. France Kidney Cancer Drugs Market 16.5. France Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 16.6. France Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 16.7. France Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 17. Eastern Europe Kidney Cancer Drugs Market 17.1. Eastern Europe Kidney Cancer Drugs Market Overview 17.2. Eastern Europe Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 17.3. Eastern Europe Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 17.4. Eastern Europe Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 18. Russia Kidney Cancer Drugs Market 18.1. Russia Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 18.2. Russia Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 18.3. Russia Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 19. North America Kidney Cancer Drugs Market 19.1. North America Kidney Cancer Drugs Market Overview 19.2. North America Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 19.3. North America Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 19.4. North America Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 20. USA Kidney Cancer Drugs Market 20.1. USA Kidney Cancer Drugs Market Overview 20.2. USA Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 20.3. USA Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 20.4. USA Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 21. South America Kidney Cancer Drugs Market 21.1. South America Kidney Cancer Drugs Market Overview 21.2. South America Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 21.3. South America Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 21.4. South America Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 22. Brazil Kidney Cancer Drugs Market 22.1. Brazil Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 22.2. Brazil Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 22.3. Brazil Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 23. Middle East Kidney Cancer Drugs Market 23.1. Middle East Kidney Cancer Drugs Market Overview 23.2. Middle East Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 23.3. Middle East Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 23.4. Middle East Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 24. Africa Kidney Cancer Drugs Market 24.1. Africa Kidney Cancer Drugs Market Overview 24.2. Africa Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 24.3. Africa Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 24.4. Africa Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 25. Kidney Cancer Drugs Market Competitive Landscape And Company Profiles 25.1. Kidney Cancer Drugs Market Competitive Landscape 25.2. Kidney Cancer Drugs Market Company Profiles 25.2.1. Bayer AG 25.2.1.1. Overview 25.2.1.2. Products and Services 25.2.1.3. Strategy 25.2.1.4. Financial Performance 25.2.2. Pfizer Inc 25.2.2.1. Overview 25.2.2.2. Products and Services 25.2.2.3. Strategy 25.2.2.4. Financial Performance 25.2.3. Novartis International AG 25.2.3.1. Overview 25.2.3.2. Products and Services 25.2.3.3. Strategy 25.2.3.4. Financial Performance 25.2.4. Exelixis, Inc 25.2.4.1. Overview 25.2.4.2. Products and Services 25.2.4.3. Strategy 25.2.4.4. Financial Performance 25.2.5. F. Hoffmann-La Roche Ag 25.2.5.1. Overview 25.2.5.2. Products and Services 25.2.5.3. Strategy 25.2.5.4. Financial Performance 26. Key Mergers And Acquisitions In The Kidney Cancer Drugs Market 27. Kidney Cancer Drugs Market Trends And Strategies 28. Product Pipeline Analysis 29. Kidney Cancer Drugs Market Future Outlook and Potential Analysis 30. Appendix 30.1. Abbreviations 30.2. Currencies 30.3. Research Inquiries 30.4. The Business Research Company 30.5. Copyright And Disclaimer
List of Tables
Table 1: Global Historic Market Growth, 2015-2019, $ Billion Table 2: Global Forecast Market Growth, 2015-2022F, 2025F, 2030F, $ Billion Table 3: Global Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 4: Global Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 5: Global Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 6: Global Kidney Cancer Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 7: Global Kidney Cancer Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 8: Asia-Pacific, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 9: Asia-Pacific, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 10: Asia-Pacific, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 11: China, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 12: China, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 13: China, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 14: India, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 15: India, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 16: India, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 17: Japan, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 18: Japan, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 19: Japan, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 20: Australia, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 21: Australia, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 22: Australia, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 23: Indonesia, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 24: Indonesia, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 25: Indonesia, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 26: South Korea, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 27: South Korea, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 28: South Korea, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 29: Western Europe, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 30: Western Europe, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 31: Western Europe, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 32: UK, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 33: UK, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 34: UK, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 35: Germany, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 36: Germany, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 37: Germany, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 38: France, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 39: France, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 40: France, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 41: Eastern Europe, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 42: Eastern Europe, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 43: Eastern Europe, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 44: Russia, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 45: Russia, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 46: Russia, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 47: North America, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 48: North America, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 49: North America, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 50: USA, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 51: USA, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 52: USA, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 53: South America, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 54: South America, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 55: South America, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 56: Brazil, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 57: Brazil, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 58: Brazil, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 59: Middle East, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 60: Middle East, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 61: Middle East, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 62: Africa, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 63: Africa, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 64: Africa, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 65: Bayer AG Financial Performance Table 66: Pfizer Inc Financial Performance Table 67: Novartis International AG Financial Performance Table 68: Exelixis, Inc Financial Performance Table 69: F. Hoffmann-La Roche Ag Financial Performance
List of Figures
Figure 1: Global Historic Market Growth, 2015-2019, $ Billion Figure 2: Global Forecast Market Growth, 2015-2022F, 2025F, 2030F, $ Billion Figure 3: Global Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 4: Global Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 5: Global Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 6: Global Kidney Cancer Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 7: Global Kidney Cancer Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 8: Asia-Pacific, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 9: Asia-Pacific, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 10: Asia-Pacific, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 11: China, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 12: China, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 13: China, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 14: India, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 15: India, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 16: India, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 17: Japan, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 18: Japan, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 19: Japan, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 20: Australia, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 21: Australia, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 22: Australia, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 23: Indonesia, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 24: Indonesia, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 25: Indonesia, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 26: South Korea, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 27: South Korea, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 28: South Korea, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 29: Western Europe, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 30: Western Europe, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 31: Western Europe, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 32: UK, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 33: UK, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 34: UK, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 35: Germany, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 36: Germany, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 37: Germany, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 38: France, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 39: France, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 40: France, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 41: Eastern Europe, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 42: Eastern Europe, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 43: Eastern Europe, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 44: Russia, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 45: Russia, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 46: Russia, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 47: North America, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 48: North America, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 49: North America, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 50: USA, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 51: USA, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 52: USA, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 53: South America, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 54: South America, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 55: South America, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 56: Brazil, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 57: Brazil, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 58: Brazil, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 59: Middle East, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 60: Middle East, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 61: Middle East, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 62: Africa, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 63: Africa, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 64: Africa, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 65: Bayer AG Financial Performance Figure 66: Pfizer Inc Financial Performance Figure 67: Novartis International AG Financial Performance Figure 68: Exelixis, Inc Financial Performance Figure 69: F. Hoffmann-La Roche Ag Financial Performance
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
